Influence of C-159T SNP of the CD14 gene promoter on lung function in smokers

Respiratory Medicine

Volumn 103, Issue 9, 2009, Pages 1358-1365

  Zhou, Haibo ^a,b   Alexis, Neil E ^a   Almond, Martha ^a   Donohue, James ^a   LaForce, Craig ^a,c   Bromberg, Philip A ^a   Peden, David B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c North Carolina Clinical Research   (United States)

Author keywords

CD14; COPD; Endotoxin; Gene environment interaction; Smoking

Indexed keywords

CD14 ANTIGEN; CYTOSINE; THYMINE;

ADULT; ARTICLE; ASTHMA; CD14 GENE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ANTIGENS, CD14; ASTHMA; ENDOTOXINS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING;

EID: 68049127970     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.03.007     Document Type: Article

References (36)

1. Vercelli D. Genetics, epigenetics, and the environment: switching, buffering, releasing. J Allergy Clin Immunol 113 (2004) 381-386
2. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 270 (2002) 109-120
3. Brass D.M., Hollingsworth J.W., McElvania-Tekippe E., Garantzios S., Hossain I., and Schwartz D.A. CD14 is an essential mediator of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 293 (2007) 77-83
4. Alexis N., Eldridge M., Reed W., Bromberg P., and Peden D.B. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol 107 (2001) 31-35
5. Domagala-Kulawik J., Maskey-Warzechowska M., Kraszewska I., and Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 123 (2003) 1054-1059
6. Regueiro V., Campos M.A., Morey P., Sauleda J., Agustí A.G., Garmendia J., et al. Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur Respir J 33 2 (2009 Feb) 273-281
7. Hasday J.D., Bascom R., Costa J.J., Fitzgerald T., and Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 115 (1999) 829-835
8. Larsson L., Szponar B., and Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 14 (2004) 421-424
9. Patel I.S., Seemungal T.A.R., Wilks M., Lloyd-Owen S.J., Donaldson G.C., and Wedzicha J.A. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57 (2002) 759-764
10. Martinez F.D. Gene-environment interactions in asthma and allergies: a new paradigm to understand disease causation. Immunol Allergy Clin North Am 25 (2005) 709-721
11. LeVan T.D., Von Essen S., Romberger D.J., Lambert G.P., Martinez F.D., Vasquez M.M., et al. Polymorphisms in the CD14 gene associated with pulmonary function in farmers. Am J Respir Crit Care Med 171 (2005) 773-779
12. Palmer S.M., Klimecki W., Yu L., Reinsmoen N.L., Snyder L.D., Ganous T.M., et al. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant 7 3 (2007) 693-699
13. Baldini M., Lohman I.C., Halonen M., Erickson R.P., Holt P.G., and Martinez F.D. A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20 (1999) 976-983
14. Keskin O., Birben E., Sackesen C., Soyer O.U., Alyamac E., Karaaslan C., et al. The effect of CD14-c159 T genotypes on the cytokine response to endotoxin by peripheral blood mononuclear cells from asthmatic children. Ann Allergy Asthma Immunol 97 (2006) 321-328
15. Koppelman G.H., Reijmerink N.E., Colin S.O., Howard T.D., Whittaker P.A., Meyers D.A., et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 163 (2001) 965-969
16. Baldini M., Vercelli D., and Martinez F.D. CD14: an example of gene by environment interaction in allergic disease. Allergy 57 (2002) 188-192
17. Zambelli-Weiner A., Ehrlich E., Stockton M.L., Grant A.V., Zhang S., Levett P.N., et al. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J Allergy Clin Immunol 115 (2005) 1203-1209
18. Meyers D.A., Postma D.S., Stine O.C., Koppelman G.H., Ampleford E.J., Jongepier H., et al. Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol 115 (2005) 1169-1175
19. Choudhry S., Avila P.C., Nazario S., Ung N., Kho J., Rodriguez-Santana J.R., et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. Am J Respir Crit Care Med 172 (2005) 173-182
20. Williams L.K., McPhee R.A., Ownby D.R., Peterson E.L., James M., Zoratti E.M., et al. Gene-environment interactions with CD14 C-260 T and their relationship to total serum IgE levels in adults. J Allergy Clin Immunol 118 (2006) 851-857
21. Lodrup Carlsen K.C., Lovik M., Granum B., Mowinckel P., and Carlsen K.H. Soluble CD14 at 2 yr of age: gender-related effects of tobacco smoke exposure, recurrent infections and atopic diseases. Pediatr Allergy Immunol 17 (2006) 304-312
22. Arroyo-Espliguero R., Avanzas P., Jeffery S., and Kaski J.C. CD14 and toll-like receptor 4: a link between infection and acute coronary events?. Heart 90 (2004) 983-988
23. Hohda S., Kimura A., Sasaoka T., Hayashi T., Ueda K., Yasunami M., et al. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 44 (2003) 613-622
24. Hubacek J.A., Rothe G., Pit'ha J., Skodova Z., Stanek V., Poledne R., et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218-3220
25. Amar J., Ruidavets J.B., Bal dit S.C., Bongard V., Boccalon H., Chamontin B., et al. CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens 22 (2004) 1523-1528
26. Knudson R.J., Slatin R.C., Lebowitz M.D., and Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 113 (1976) 587-600
27. Rosner B. Fundamentals of biostatistics. 6th ed. (2006), Duxbury Press, Boston
28. SAS Institute. SAS/STAT user's guide, version 9.1 (2005), SAS Institute, Cary, NC
29. Alexis N.E., and Peden D.B. Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14. J Allergy Clin Immunol 108 (2001) 577-580
30. Chhabra S.K., and Bhatnagar S. Comparison of bronchodilator responsiveness in asthma and chronic obstructive lung disease. Indian J Chest Dis Allied Sci 44 (2002) 91-97
31. Walker P.P., and Calverley P.M. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease. COPD 5 (2008) 147-152
32. O'Donnell D.E., Forkert L., and Webb L. Evaluation of bronchodilator response in patients with "irreversible" emphysema. Eur Respir J 18 (2001) 914-920
33. Schermer T., Heijdra Y., Zadal S., Van den Bemt L., Winter L.B., Dekhuijzen R., et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 101 (2007) 1355-1362
34. Simpson A., John S.L., Jury F., Niven R., Woodcock A., Ollier W.E., et al. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med 174 (2006) 386-392
35. Jerrard-Dunne P., Sitzer M., Risley P., Buehler A., von Kegler S., and Markus H.S. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 35 (2004) 2438-2443
36. Risley P., Jerrard-Dunne P., Sitzer M., Buehler A., von Kegler S., and Markus H.S. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 34 (2003) 600-604